Jennifer Rose-Nussbaumer

President, Ocular Microbiology Interest Group · Stanford Health Care

Credentials: · · ·

History

Glaucoma Drainage Device and Endothelial Cell Density Loss Compare (DECLARE) Trial
National Eye Institute · UG1
PI · $4.4M · University of California, San Francisco
2023–2028
Descemet Endothelial Thickness Comparison Trial (DETECT)
National Eye Institute · UG1
Contact PI · $5.7M · Stanford University
2021–2027
Steroids and Cross-Linking for Ulcer Treatment (SCUT II)
National Eye Institute · UG1
PI · $3.9M · University of California, San Francisco
2019–2026
Predictions of Response to Treatment in Fungal Keratitis
National Eye Institute · K23
Contact PI · $1.2M · Kaiser Foundation Research Institute
2015–2021

Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II
Principal investigator · Active not recruiting · Phase 3
University of California, San Francisco
2024–2027
Descemet Endothelial Thickness Comparison Trial II
Principal investigator · Recruiting · Phase 3
Stanford University
2023–2028
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction
Principal investigator · Completed · Phase 3
University of California, San Francisco
2022–2025
Descemet Endothelial Thickness Comparison Trial I
Principal investigator · Active not recruiting · Phase 3
Stanford University
2022–2027